Tianshui Zhongxing Bio-technology Co Ltd Financial Flexibility Index
Tianshui Zhongxing Bio-technology Co Ltd financial flexibility index. Tianshui Zhongxing Bio-technology Co Ltd (002772) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥358.63 Million (operating CF CN¥207.31 Million minus capex CN¥151.32 Million) represents 0% of total liabilities (CN¥3.43 Billion). Explore Tianshui Zhongxing Bio-technology Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tianshui Zhongxing Bio-technology Co Ltd (2011–2025)
Financial flexibility index of Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Tianshui Zhongxing Bio-technology Co Ltd across 15 annual periods. Check Tianshui Zhongxing Bio-technology Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Tianshui Zhongxing Bio-technology Co Ltd Financial Flexibility Index by Year (2011–2025)
Tianshui Zhongxing Bio-technology Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Tianshui Zhongxing Bio-technology Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Tianshui Zhongxing Bio-technology Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CN¥1.06 Billion | CN¥503.52 Million | CN¥3.43 Billion | ▲ +19.3% |
| 2024 | 0.26x | CN¥739.67 Million | CN¥494.52 Million | CN¥2.87 Billion | ▲ +7.6% |
| 2023 | 0.24x | CN¥631.50 Million | CN¥524.50 Million | CN¥2.64 Billion | ▲ +3.1% |
| 2022 | 0.23x | CN¥739.56 Million | CN¥493.70 Million | CN¥3.18 Billion | ▲ +702.5% |
| 2021 | -0.04x | CN¥-127.21 Million | CN¥-413.68 Million | CN¥3.30 Billion | ▼ -114.3% |
| 2020 | 0.27x | CN¥769.06 Million | CN¥389.32 Million | CN¥2.85 Billion | ▼ -36.4% |
| 2019 | 0.42x | CN¥1.02 Billion | CN¥359.15 Million | CN¥2.41 Billion | ▼ -29.1% |
| 2018 | 0.60x | CN¥883.46 Million | CN¥231.79 Million | CN¥1.48 Billion | ▲ +22.8% |
| 2017 | 0.49x | CN¥709.48 Million | CN¥207.34 Million | CN¥1.46 Billion | ▼ -37.0% |
| 2016 | 0.77x | CN¥713.04 Million | CN¥233.39 Million | CN¥922.12 Million | ▲ +26.2% |
| 2015 | 0.61x | CN¥395.10 Million | CN¥209.43 Million | CN¥644.80 Million | ▼ -4.6% |
| 2014 | 0.64x | CN¥361.55 Million | CN¥170.31 Million | CN¥563.09 Million | ▼ -5.3% |
| 2013 | 0.68x | CN¥264.77 Million | CN¥93.03 Million | CN¥390.55 Million | ▼ -56.9% |
| 2012 | 1.57x | CN¥327.57 Million | CN¥94.56 Million | CN¥208.41 Million | ▼ -18.6% |
| 2011 | 1.93x | CN¥219.48 Million | CN¥93.01 Million | CN¥113.73 Million | — |